Xtandi 40 MG capsule 120S

Ended Awarded Last action

Contract number
SPE2DR26FFCF9
Awardee
Awarding agency
Obligated
$44,222

Award facts

Contract value 100% obligated
$44,221.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $44,221.60 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Xtandi 40 mg capsules (120 count) under a firm fixed-price structure.

DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order was placed under the company's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. Place of performance is Park Ridge, Illinois. Ultimate completion date for this order is March 2, 2026.

Quick answers

Who was awarded contract SPE2DR26FFCF9?

SPE2DR26FFCF9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 27, 2026.

How much is contract SPE2DR26FFCF9 worth?

The government has obligated $44,222 on SPE2DR26FFCF9.

Is contract SPE2DR26FFCF9 an order under another contract?

Yes. SPE2DR26FFCF9 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.

Was contract SPE2DR26FFCF9 competed?

The extent of competition for SPE2DR26FFCF9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award